1 Min Read
Sept 30 (Reuters) -
* James Flynn reports 4.21 percent passive stake in Catabasis Pharmaceuticals Inc as of September 28 - SEC filing Source text bit.ly/2dJKqb2 Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.